The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 17, 2026

Filed:

Jul. 27, 2020
Applicant:

Health Research, Inc., Buffalo, NY (US);

Inventors:

Andrei Bakin, Buffalo, NY (US);

Justin Zonneville, Webster, NY (US);

Assignee:

Health Research, Inc., Buffalo, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/7072 (2006.01); A61K 31/502 (2006.01); A61K 31/5025 (2006.01); A61K 31/513 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7072 (2013.01); A61K 31/502 (2013.01); A61K 31/5025 (2013.01); A61K 31/513 (2013.01); A61P 35/00 (2018.01);
Abstract

Provided are methods and formulations for the treatment of p53-deficient cancers using a combinational drug strategy which enhances DNA damage in p53 deficient cells while not allowing cells to escape cell death by activation of p53-p21 signaling. Wild-type p53 carriers, on the other hand, respond with activation of p53-p21 signaling and cell-cycle arrest, thereby escaping cell death. The methods involve administering to an individual in need of treatment a combination of one or more poly (ADP ribose) polymerase inhibitors (PARPi) and one or more deoxyuridine analogs. Pharmaceutical formulations comprising PARPi and dU analogs are also provided.


Find Patent Forward Citations

Loading…